1. Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals

   • Tushar Srivastava
   • Nicholas R. Latimer
   • Paul Tappenden

   Practical Application 19 May 2021 Pages: 869 - 878

   

2. Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies

   • Ana Duarte
   • Simon Walker
   • Mark Sculpher

   Review Article 19 June 2021 Pages: 879 - 887

   

3. Do Costs in the Education Sector Matter? A Systematic Literature Review of the Economic Impact of Psychosocial Problems on the Education Sector

   • Irina Pokhilenko
   • Luca M. M. Janssen
   • Aggie T. G. Paulus

   Systematic Review Open access 14 June 2021 Pages: 889 - 900

   

4. Utility Values Associated with Atypical Hemolytic Uremic Syndrome-Related Attributes: A Discrete Choice Experiment in Five Countries

   • Kate Williams
   • Daniel Aggio
   • Yan Wang

   Original Research Article Open access 01 July 2021 Pages: 901 - 912

   

5. Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study

   • Becky Pennington
   • Abualbishr Alshreef
   • John Brazier

   Original Research Article Open access 26 April 2021 Pages: 913 - 927

   

6. A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population

   • Emily McDool
   • Clara Mukuria
   • John Brazier

   Original Research Article Open access 27 May 2021 Pages: 929 - 940

   

7. The Cost-Effectiveness of Lorlatinib Versus Chemotherapy as a Second- or Third-Line Treatment in Anaplastic Lymphoma Kinase (ALK)-Positive Non-small-cell Lung Cancer in Sweden

   • Fredrik O. L. Nilsson
   • Sandra T. Asanin
   • Sarah Smith

   Original Research Article Open access 03 June 2021 Pages: 941 - 952

   

8. Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer

   • Yat Hang To
   • Koen Degeling
   • Jeanne Tie

   Original Research Article 05 June 2021 Pages: 953 - 964

   

9. Comment on Keeney et al.’s “Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer Screening”

   • James F. O’Mahony

   Letter to the Editor 17 July 2021 Pages: 965 - 967

10. Response to Comment on Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer Screening

    • Edna Keeney
    • Howard Thom
    • Sabina Sanghera

    Letter to the Editor 17 July 2021 Pages: 969 - 970

11. Retraction Note to: The EQ-5D-5L Valuation Study in Egypt

    • Sahar A. Al Shabasy
    • Maggie M. Abbassi
    • Samar F. Farid

    Retraction Note Open access 15 June 2021 Pages: 971 - 971